drugset / Trial / NCT04133649
Evaluation of Safety and Tolerability of Libella Gene Therapy for the Treatment of Aging: AAV- hTERT
NaSingle-groupOpen-labelTreatment
Summary
Using gene therapy to express active telomerase (hTERT) in humans has the potential to treat many of the age related diseases, including Aging itself. This study will entail treating subjects with hTERT delivered via transduction using AAV. The goal is to extend the telomeres to prevent, delay, or even reverse Aging.
Timeline
- Start
- 2019-10-17
- Primary completion
- 2021-01
- Completion
- 2021-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AAV-hTERT | Gene therapy (AAV / viral vector) | — | Intravenous |
Indications
No indication recorded.